Which outcome measures in SLE clinical trials best reflect medical judgment?
نویسندگان
چکیده
منابع مشابه
Which outcome measures in SLE clinical trials best reflect medical judgment?
OBJECTIVES TO COMPARE TWO MEASURES OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) RESPONSE: the British Isles Lupus Assessment Group (BILAG)-based Composite Lupus Assessment (BICLA) and the Systemic Lupus Responder Index (SRI) against a clinician's assessment of improvement. METHODS Ninety-one lupus patients were identified with two visits at which Systemic Lupus Erythematosus Disease Activity Index (...
متن کاملOutcome measures in amyotrophic lateral sclerosis clinical trials.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an average survival of 3-5 years. While therapies for ALS remain limited, basic and translational ALS research has been host to numerous influential discoveries in recent years. These discoveries have led to a large pipeline of potential therapies that await testing in clinical trials. Until recently, ALS clinical trials ha...
متن کاملNovel Outcome Measures for Clinical Trials in Cystic Fibrosis
Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF transmembrane regulator protein. With increased understanding of the molecular mechanisms underlying CF and the development of new therapies there comes the need to develop new outcome measures to assess the disease, its progression and response to treatment. As there are limitations to the curr...
متن کاملOutcome Measures in Clinical Trials for Multiple Sclerosis
Due to the heterogeneous nature of the disease, it is a challenge to capture disease activity of multiple sclerosis (MS) in a reliable and valid way. Therefore, it can be difficult to assess the true efficacy of interventions in clinical trials. In phase III trials in MS, the traditionally used primary clinical outcome measures are the Expanded Disability Status Scale and the relapse rate. Seco...
متن کاملEvaluating patient-based outcome measures for use in clinical trials.
By means of the above criteria, further primary research and consensus-type processes should be used to evaluate leading instruments in the different fields and specialties of health care to improve use of patient-based outcome measures in trials. Primary research is needed either in the form of methodological additions to substantive clinical trials (for example comparing the performance of tw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Lupus Science & Medicine
سال: 2014
ISSN: 2053-8790
DOI: 10.1136/lupus-2013-000005